Experience with immunotherapy in malignant melanoma
Keywords:
melanoma, immunologyAbstract
16 pathiens suffering from malign melanoma were subject to complementary treatment by B. C. G. In spite of the fact that the number of cases was insufficient and that response varied, the patients derived benefit from this therapy.
Survival of patientes treated by intratumoral B. C. G. and of those who receivect B. C. G. by other routes, was the same.
Inmunotherapy is as yet in an experimental stage and hence patients have to be carefully selected and
controlled in specialized centres.
Serious complications may derive from the application of this treatment and in this series they amounted to 3 cases.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
License
All articles, videos and images published in Revista Cirugía del Uruguay are under the Creative Commons CC licenses, which is a complement to the traditional copyright, in the following terms: first, the authorship of the referred document must always be acknowledged and secondly none of the article or work published in the journal may have commercial purposes of any nature. The authors retain their copyrights and give the magazine the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License license that allows the work to be shared whenever the initial publication is indicated in this journal.
